News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY) Hepatitis C Drug Trial Turns Fatal for Patient



9/17/2012 7:56:39 AM

When Jessica and Brian Starkey of Leavenworth County were diagnosed with hepatitis C infections last year, they didn’t have insurance coverage for treatment. But Jessica’s doctor said there was still a chance they could get help. Researchers in Kansas City were enrolling hepatitis C patients in a national clinical trial. They offered powerful drug cocktails featuring a promising new experimental drug to kill the virus. And it was free. The drug, which went by the code name BMS-986094, was among a growing number of experimental antiviral medications being developed to treat hepatitis C, a liver-destroying virus that infects more than 3 million people in the United States and as many as 200 million worldwide.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES